The AHEAD 3–45 Study: Design of a prevention trial for Alzheimer’s disease

INTRODUCTION: The Alzheimer’s disease (AD) continuum begins with a long asymptomatic or preclinical stage, during which amyloid beta (Aβ) is accumulating for more than a decade prior to widespread cortical tauopathy, neurodegeneration, and manifestation of clinical symptoms. The AHEAD 3–45 Study (BA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafii, Michael S., Sperling, Reisa A., Donohue, Michael C., Zhou, Jin, Roberts, Claire, Irizarry, Michael C., Dhadda, Shobha, Sethuraman, Gopalan, Kramer, Lynn D, Swanson, Chad J, Li, David, Krause, Stephen, Rissman, Robert A., Walter, Sarah, Raman, Rema, Johnson, Keith A., Aisen, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929028/
https://www.ncbi.nlm.nih.gov/pubmed/35971310
http://dx.doi.org/10.1002/alz.12748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929028/
https://www.ncbi.nlm.nih.gov/pubmed/35971310
http://dx.doi.org/10.1002/alz.12748

Ejemplares similares